当前位置:首页 - 行情中心 - 毕得医药(688073) - 财务分析

毕得医药

(688073)

  

流通市值:57.73亿  总市值:57.73亿
流通股本:9088.29万   总股本:9088.29万

毕得医药(688073)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.47亿元,每股收益0.54元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益209996.75万元,未分配利润36665.44万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产254213.05万元,负债44216.29万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入323,276,733.741,323,810,726.7979,111,093.03627,526,589.12
营业总成本262,853,915.441,107,810,422.06809,767,058.8522,427,598.32
其他经营收益
营业利润61,695,880.68196,498,103.92159,784,517.84100,639,047.56
利润总额61,379,932.03195,427,483.42159,566,465.22100,843,826.91
净利润46,829,140.4151,739,651.59119,734,016.4173,406,059.54
每股收益
其他综合收益3,042,449.366,977,647.181,945,985.632,453,798.93
综合收益总额49,871,589.76158,717,298.77121,680,002.0475,859,858.47
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计2,346,333,126.052,304,824,720.622,369,501,774.042,335,754,043.1
非流动资产:
非流动资产合计195,797,355.28211,973,168.88193,459,925.96194,435,725
资产总计2,542,130,481.332,516,797,889.52,562,961,7002,530,189,768.1
流动负债:
流动负债合计315,909,520.3341,819,464.7520,035,221.03542,520,437.38
非流动负债:
非流动负债合计126,253,418.6129,583,419.4240,464,112.5438,943,676.53
负债合计442,162,938.9471,402,884.12560,499,333.57581,464,113.91
所有者权益(或股东权益):
归属于母公司股东权益合计2,099,967,542.432,045,395,005.382,002,462,366.431,948,725,654.19
股东权益合计2,099,967,542.432,045,395,005.382,002,462,366.431,948,725,654.19
负债和股东权益合计2,542,130,481.332,516,797,889.52,562,961,7002,530,189,768.1
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计363,417,116.611,480,900,323.86997,205,055.86631,163,417.65
经营活动现金流出小计323,986,198.871,452,576,108.55988,472,351.48615,051,229.06
经营活动产生的现金流量净额39,430,917.7428,324,215.318,732,704.3816,112,188.59
投资活动产生的现金流量:
投资活动现金流入小计481,389,716.424,261,007,851.793,368,193,225.842,001,219,043.67
投资活动现金流出小计573,540,477.344,336,155,494.783,486,621,789.062,399,795,383.16
投资活动产生的现金流量净额-92,150,760.92-75,147,642.99-118,428,563.22-398,576,339.49
筹资活动产生的现金流量:
筹资活动现金流入小计137,099.4255,691,856.85279,935,276.04271,010,787.63
筹资活动现金流出小计7,036,223.55393,726,882.94309,855,510.11278,428,623.15
筹资活动产生的现金流量净额-6,899,124.15-138,035,026.09-29,920,234.07-7,417,835.52
汇率变动对现金及现金等价物的影响-8,910,177.57-8,774,772.59-3,268,217.273,350,488.57
现金及现金等价物净增加额-68,529,144.9-193,633,226.36-142,884,310.18-386,531,497.85
期末现金及现金等价物余额834,458,326.99902,987,471.89953,736,388.07710,089,200.4
补充资料:
现金及现金等价物的净增加额--193,633,226.36--386,531,497.85
最新报告期:2026-03-01
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
开源证券余汝意,石启正2.503.13--2026-03-01
TOP↑